Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Clin Pract Oncol. 2008 Jan;5(1):4-5. Epub 2007 Nov 27.

Adjuvant use of interferon alpha 2b is not justified in patients with stage IIb/III melanoma.

Author information

1
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G Venezian 1, Milan 20133, Italy. emilio.bajetta@istitutotumori.mi.it
PMID:
18043604
DOI:
10.1038/ncponc1007
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center